Bristol Myers Squibb (BMY) came out with quarterly earnings of $1.80 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to loss of $4.40 per share a year ago.

I will continue by comparing the revenue growth rates of Merck and Bristol-Myers Squibb, how often these two giants beat Wall Street analysts' expectations, and also compare their price-to-sales ...

Bristol-Myers Squibb has shown exceptional success in addressing challenges directly related to the introduction of generic versions of Revlimid and Sprycel. So, the gem in its oncology franchise ...

Sandra Leung, one of the longest-serving legal chiefs in the pharmaceutical industry, plans to retire from Bristol Myers Squibb in 2025 after nearly 33 years with the company. Leung will be ...

Jefferies analyst Akash Tewari upgraded Bristol-Myers Squibb from Hold to Buy and raised the price target to $70 Tewari highlighted strong sales expectations for Cobenfy and improved financial ...

Bristol Myers’ lawsuit asserts that manufacturers can choose between rebate and discount pricing models under the 340B statute. Bristol Myers highlights issues like drug diversion and duplicate ...

NEW YORK (Reuters) - Bristol Myers Squibb (BMY) was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs ...

An attorney for Bristol Myers Squibb on Friday urged a New York federal judge to dismiss a $6.4 billion action against the pharmaceutical giant, claiming the plaintiff has no subject matter ...

Bristol-Myers Squibb's stock climbed as much as 11% on Friday, its biggest intraday surge since 2008, after beating profit forecasts and raising full-year guidance. The drugmaker's second-quarter ...

Bristol Myers has delivered some underwhelming returns for investors in the past decade. The company's future is uncertain as it faces multiple patent cliffs. Management has a plan for more growth ...

Bristol Myers Squibb Bristol Myers Squibb (NYSE: BMY) recently reported its Q1 results, with revenues and earnings above the street estimates. The company reported revenue of $11.9 billion and an ...